v3.26.1
Segments (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]    
Stock-based compensation expense $ 13,621 $ 5,852
Reportable Segment    
Segment Reporting Information [Line Items]    
Nonclinical expenses 824 570
Clinical expenses 24,865 9,966
CMC expenses 9,657 5,106
Salaries, benefits and related costs 8,502 6,164
Stock-based compensation expense 5,992 2,402
Other 244 229
Research and development $ 50,084 $ 24,437